Healthcare

Patent Office is asking the right questions to lower drug costs

By
Published January 6, 2023 11:00am ET
Add Washington Examiner on Google
Patent Office is asking the right questions to lower drug costs
The main activities that drug makers get penalized for are illegally marketing a drug to a doctor, and deliberately overcharging Medicare or Medicaid. | R Carner

The United States Patent and Trademark Office (USPTO) is finally asking the right questions.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Beltway Op-Eds Drug Policy Patent Law